A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients

NCT02765815 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped competing protocol

Conditions

Osteoarthritis, Knee
Arthroplasty, Replacement, Knee

Interventions

DRUG: Liposomal bupivacaine, 266mg
DRUG: Bupivacaine 0.5 % with Epinephrine
DRUG: Ketorolac 30mg
DRUG: Morphine 10mg
DRUG: Bupivacaine 0.25% with Epinephrine

Sponsor

Holy Cross Hospital, Florida